Third, in clinical trial B no measurements were performed on anthropometric or surrogate metabolic parameter to assess insulin resistance other than BMI, lack of overt dyslipidemia and lack of diabetes to establish whether subjects were metabolically stable. Here, INS is linked to metabolic syndrome.